What is the current stock price of Materialise N.V. (MTLS)?

As of the latest market data, Materialise N.V. (MTLS) is trading at $5.07. The stock has seen a gain of 1.00% today.

Does Materialise N.V. (MTLS) pay a dividend?

Based on current data, Materialise N.V. does not have a confirmed active dividend policy.

What is the market cap of Materialise N.V.?

The current market capitalization of Materialise N.V. (MTLS) is approximately unavailable.

MTLS

Materialise N.V.·Technology

5.07

0.996%(+0.05)

Market Closed

5.54

9.270%(+0.47)

After Hours

Last Updated: — ET

52W L: $4.3652W H: $6.80

MTLS NEWS

globenewswire.com

Mar 31

Materialise to Transfer RapidFit Business to Its Management Team

Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, announces the decision to transfer its RapidFit business to its management team. Following the transaction, RapidFit will continue as an independent company under the ownership and leadership of the same team under the RapidFit name.

defenseworld.net

Mar 11

Materialise (NASDAQ:MTLS) Stock Crosses Below Fifty Day Moving Average – Here’s What Happened

Materialise NV (NASDAQ: MTLS - Get Free Report)'s stock price crossed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $5.52 and traded as low as $5.18. Materialise shares last traded at $5.21, with a volume of 60,331 shares. Wall Street Analyst Weigh In MTLS

seekingalpha.com

Feb 24

Materialise: Medical And Software-Led Rebound

Materialise is poised for a return to consistent growth and improving margins, led by Medical strength and stabilization of its Software business. The Manufacturing segment faces ongoing headwinds, but expansion into aerospace and defense could create a modest rebound over the next few years. The combination of a low valuation, consistent growth, and higher margins should lead the stock higher, which will be supported by a share buyback program.

seekingalpha.com

Feb 19

Materialise NV (MTLS) Q4 2025 Earnings Call Transcript

businesswire.com

Feb 19

Materialise Reports Fourth Quarter and Full Year 2025 Results

LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Mat.

businesswire.com

Feb 4

Materialise NV to Report Fourth Quarter 2025 Earnings on Thursday, February 19, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the fourth quarter ended December 31, 2025 on Thursday, February 19, 2026 at 2:30 a.m. ET/8:30 a.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2025 financial results on Thursday, February 19, 2026 at.

Company Profile

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Sector

Technology

Industry

Software - Application

Employees

488

IPO Date

2014-06-25

Beta

1.20

Websitewww.materialise.com↗